Hormone-Refractory Prostate Cancer Withdrawn Phase Trials for Cyclophosphamide (DB00531)

Also known as: Hormone Refractory Prostate Cancer Disease / Hormone Refractory Prostate Cancer / Castration-resistant prostate cancer / Hormone refractory prostate cancer (disorder)

IndicationStatusPhase
DBCOND0030169 (Hormone-Refractory Prostate Cancer)WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02867345PD-1 Knockout Engineered T Cells for Castration Resistant Prostate Cancer